144 related articles for article (PubMed ID: 22280809)
1. Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer.
Bhide SA; Gulliford S; Schick U; Miah A; Zaidi S; Newbold K; Nutting CM; Harrington KJ
Radiother Oncol; 2012 Apr; 103(1):88-91. PubMed ID: 22280809
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy.
Bhide SA; Gulliford S; Fowler J; Rosenfelder N; Newbold K; Harrington KJ; Nutting CM
Radiother Oncol; 2010 Oct; 97(1):86-91. PubMed ID: 20826031
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
Otter S; Schick U; Gulliford S; Lal P; Franceschini D; Newbold K; Nutting C; Harrington K; Bhide S
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):507-15. PubMed ID: 26460992
[TBL] [Abstract][Full Text] [Related]
4. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer.
Bhide SA; Gulliford S; Kazi R; El-Hariry I; Newbold K; Harrington KJ; Nutting CM
Radiother Oncol; 2009 Dec; 93(3):539-44. PubMed ID: 19883951
[TBL] [Abstract][Full Text] [Related]
5. Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT±concurrent chemotherapy.
Moroney LB; Helios J; Ward EC; Crombie J; Wockner LF; Burns CL; Spurgin AL; Blake C; Kenny L; Hughes BG
Oral Oncol; 2017 Jan; 64():1-8. PubMed ID: 28024718
[TBL] [Abstract][Full Text] [Related]
6. Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer.
Anand AK; Chaudhoory AR; Shukla A; Negi PS; Sinha SN; Babu AA; Munjal RK; Dewan AK; Kumar K; Doval DC; Vaid AK
Br J Radiol; 2008 Nov; 81(971):865-71. PubMed ID: 18941046
[TBL] [Abstract][Full Text] [Related]
7. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the Effect of Radiotherapy Dose on Chewing and Swallowing Structures in Head and Neck Cancer Patients Treated with Concomitant Chemoradiotherapy.
Baştuğ Dumbak A; Esen Aydınlı F; Yazıcı G; İncebay Ö; Yıldız Z; Yüce D; Süslü N; Kuşçu O; Kulak Kayıkcı ME
Dysphagia; 2022 Dec; 37(6):1400-1413. PubMed ID: 35075541
[TBL] [Abstract][Full Text] [Related]
9. Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients.
Orlandi E; Iacovelli NA; Rancati T; Cicchetti A; Bossi P; Pignoli E; Bergamini C; Licitra L; Fallai C; Valdagni R; Cavallo A
Oral Oncol; 2018 Nov; 86():266-272. PubMed ID: 30409311
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
11. Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures.
van der Molen L; Heemsbergen WD; de Jong R; van Rossum MA; Smeele LE; Rasch CR; Hilgers FJ
Radiother Oncol; 2013 Mar; 106(3):364-9. PubMed ID: 23540551
[TBL] [Abstract][Full Text] [Related]
12. Radiobiological modeling of radiation-induced acute mucosal toxicity (oral mucositis and pharyngeal mucositis): A single-institutional study of head-and-neck carcinoma.
Singh B; Singh G; Oinam AS; Kumar V; Vashistha R; Sidhu MS; Singh M
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0-S1715. PubMed ID: 37147947
[TBL] [Abstract][Full Text] [Related]
13. Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer.
Sanguineti G; Sormani MP; Marur S; Gunn GB; Rao N; Cianchetti M; Ricchetti F; McNutt T; Wu B; Forastiere A
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):235-42. PubMed ID: 22104358
[TBL] [Abstract][Full Text] [Related]
14. Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma.
Mogadas S; Busch CJ; Pflug C; Hanken H; Krüll A; Petersen C; Tribius S
Strahlenther Onkol; 2020 Jun; 196(6):522-529. PubMed ID: 32006068
[TBL] [Abstract][Full Text] [Related]
15. Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma.
Thomson DJ; Ho KF; Ashcroft L; Denton K; Betts G; Mais KL; Garcez K; Yap BK; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
Acta Oncol; 2015 Jan; 54(1):88-98. PubMed ID: 25279959
[TBL] [Abstract][Full Text] [Related]
16. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
[TBL] [Abstract][Full Text] [Related]
17. A prospective, comparative analysis of acute toxicity profile between three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT) in locally advanced head and neck cancer patients.
Kucha N; Soni TP; Jakhotia N; Patni N; Singh DK; Gupta AK; Sharma LM; Goyal J
Cancer Treat Res Commun; 2020; 25():100223. PubMed ID: 33120316
[TBL] [Abstract][Full Text] [Related]
18. Frequency and Evolution of Acute Oral Complications in Patients Undergoing Radiochemotherapy Treatment for Head and Neck Squamous Cell Carcinoma.
Palmieri M; Sarmento DJS; Falcão AP; Martins VAO; Brandão TB; Morais-Faria K; Ribeiro ACP; Hasséus B; Giglio D; Braz-Silva PH
Ear Nose Throat J; 2021 Sep; 100(5_suppl):449S-455S. PubMed ID: 31619067
[TBL] [Abstract][Full Text] [Related]
19. Large discrepancies between planned and actually delivered dose in IMRT of head and neck cancer. A case report.
Piermattei A; Cilla S; D'Onofrio G; Grimaldi L; Digesù C; Macchia G; Deodato F; Morganti AG
Tumori; 2007; 93(3):319-22. PubMed ID: 17679475
[TBL] [Abstract][Full Text] [Related]
20. Enteral nutrition support and treatment toxicities in patients with head and neck cancer receiving definitive or adjuvant helical intensity-modulated radiotherapy with concurrent chemotherapy.
Blake CL; Brown TE; Pelecanos A; Moroney LB; Helios J; Hughes BGM; Chua B; Kenny LM
Head Neck; 2023 Feb; 45(2):417-430. PubMed ID: 36433667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
